Proppant Market 2015-2025 Shares, Trend and Growth Report

Hydraulic fracturing, also known as fracking, is a process that has been used by gas companies since the 1940s. The process involves injecting sand, chemicals, and water into a well under carefully controlled conditions to crack or fracture solid rocks and release trapped gas deposits. The development of hydraulic fracturing technology has led to the usage of proppants. Proppants are used during hydraulic fracturing in order to keep the fissures open for the oil and gas to flow towards the well head. These are primarily of three types such as sand, resin-coated and ceramic.

Although the recent plummeting of international crude oil prices has negatively impacted the hydraulic fracturing industry, the overall outlook on the future prospects of the industry is positive. The proppant market is expected to register significant growth in the near future due to anticipated increase in global crude oil prices, which is likely to revamp the global shale industry.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-sa-455

Proppant Market: Drivers

Although the crude oil market is going through a slump, increasing energy demands all over the world are projected to provide an impetus to the market. This, in turn, is anticipated to augur well for the hydraulic fracturing- and proppant- market. After witnessing the shale boom in North America, many countries across the globe are exploring shale prospects in respective shale plays. The proppant market is expected to register increased revenues and volumes with shale exploration picking pace in such countries.

Proppant Market: Restraints

One of the key restraints in the proppant market can be attributed to the prevailing low international crude oil prices. The plummeting of crude oil prices makes shale extraction uneconomical and as a result, the proppant market revenues decline due to decreased hydraulic fracturing activity.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-sa-455

Proppant Market: Segmentation

The proppant market has been segmented into the types of proppants used for hydraulic fracturing. Sand, resin coated and ceramic are the three types of proppants used for hydraulic fracturing. Within the proppant market, sand proppant is most widely used for hydraulic fracturing. However, the type of proppant to be used in coming years most likely depends on the price of crude oil in the international market.

In terms of geography, the proppant market has been segmented into North and Central American region wherein the U.S. & Canada and Mexico is considered respectively. Amongst these regions, the North American region accounts for a leading share in the proppant market, both in terms of value as well as volume.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/proppant-market

Proppant Market: Key Players

The key players in the proppant market include U.S. Silica, Carbo Ceramics, and Hi Crush LP Partners.

Advertisements

Emerging Opportunities in Alcohol Market with Current Trends Analysis

FMI_FacebookAlcohols are the intoxicating beverage consisting of spirits, wine and beer. It is defined by the alcohol content and the major raw material used in it. For instance, spirits are mainly made by fermenting grains and sugar, whereas wine is made by fermenting fruits/berries. Indian alcohol market has been flourishing since 2001 and registered growth between 7-12% till 2011 when the growth finally declined due to heavy import taxes, state government taxes, excise duty and political instability in election season. The year 2013 was a great fall in Indian alcohol market when the spirits volume actually declined by 2-3% in India. Alcohol industry is a part of huge US$ 12 billion beverage industry of India excluding milk and milk products.

Indian alcohol market is dominated by whiskey which falls under spirit category. However, the wine market is expected to show highest growth in the forecast period. The Indian alcohol market is broadly segmented as spirits, beer and wine. Spirits are further sub-segmented into whiskey, rum/brandy, vodka, gin and others. The market is projected to register a flat growth in the forecast period.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-in-201

Consumers are largely inclined towards quality alcohol due to increasing disposable income and better standard of living. Other drivers include greater inclination towards social drinking as well as women indulging into alcohol consumption. As India has huge youth population, the demand of alcohol would remain high in the coming years. The market saw a boom in Vodka sales in past decade as Vodka was positioned as the alcohol for women. Youth largely prefer beer and the salaried youth are inclined toward whiskey and rum. In beer segment, more than 85% of the market is dominated by strong beer rather than mild.

There exists quite a few restraints in the market such as high taxes, stringent government regulations on manufacturing and selling liquor, and ban on advertisements among others. Alcohol consumption is also subjected to the overall economy’s growth in terms of gross net income per capita and household expenditure. Thus, development in the economy would give a thrust to the alcohol market further but in a less pronounced manner.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-in-201

One of the most notable trend is the demand of premium liquor among the consumers. The growth of premium segment would surpass the overall growth of alcohol market due to greater exposure towards foreign brands. India has seen a burst of high net worth individuals in past two decades and the list is ever increasing, which would fuel the growth of market in premium segment. In addition to travel retail theatres and duty free retailing would further boost the growth of premium alcohol in the market. Companies are launching exclusive new brands and products at premium prices to increase their margins and capture the upper class consumers. In September 2014, SABMiller, which also happen to be the second largest player in beer segment (after Kingfisher) launched its premium brand “Miller Ace” in India to compete with brands such as Carlsberg and Anheuser-Busch InBev.

Many international brands such as Diageo plc, PernodRicard, and The Carlsberg Group already forayed into the market with their million-dollar brands. The market is also moving towards consolidation with large number of acquisitions and joint ventures. One of the biggest mergers in recent past is that of London based Diageo plc and Indian firm United Spirits Limited, (USL). Diageo acquired 54.78 % share in USL by shelling whopping US$ 3 billion by mid-2014. USL is the dominant player in Indian alcohol market commanding majority of market share.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/indian-alcohol-market

Some of the major players in Indian Alcohol Market are United Spirits Limited, RadicoKhaitan, Jagatjit Industries, Globus Spirits, Allied Blenders and Distillers Pvt. Ltd., Sula Vineyards, SABMiller India Ltd. and John Distilleries Pvt Ltd among others.

Regenerative Medicine Market 2016-2026 Shares, Trend and Growth Report

FMI_FacebookRegenerative medicine is a category of research in tissue engineering and molecular biology which deals with the method for human cells, tissues and organs reco­nstruction to reactivate normal body function. The regenerative medicine repairs the defective cells and tissues. Regenerative medicine treats the basic cause of disease, injuries and genetic conditions. Regenerative medicine gives complete treatment of the abnormality or disease as compared to the symptomatic treatments. Regenerative medicine is a treatment technique which works in three approaches which ensure the complete eradication of the injury of the cell, tissue or organ. There are stem cells and non-stem cell (somatic) therapies which includes taking cells from healthy body organ in the body and applying these cells to the damaged area after expanding these cells in cell culture. The regenerative medicine triggers the body’s own repair mechanism to patch-up the unrepairable human tissue or organs. Regenerative medicine also consists of injecting the cord blood stem cells intravenously which treats brain injuries. Regenerative medicine gives doctors an option to use the therapy for complete eradication of the disease.

Regenerative Medicine Market: Drivers & Restraints

The regenerative medicine market is a fast growing market due to a paradigm shift in healthcare. The human stem cell science is changing rapidly & there is a requirement for manufacturing to be flexible according to change in technology. The more active, workable healthcare system is expected through regenerative medicine. There is a nonstop demand for few number of organs due to end stage organ failure which can be cured through regenerative medicine. Regenerative medicine market would be on the top spot of the healthcare market due to high demand and limited supply in upcoming years. The stem cell application and the improvement in nanotechnology is also favouring the growth of regenerative medicine market. Thousands of patients are being treated by stem cell transplant and the number can be doubled in upcoming years due to inclusion of regenerative medicine. Regenerative medicine market is tend to grow with increase in geriatric population with chronic diseases. The regulatory demands for regenerative medicine market is greater than other pharmaceutical products which is challenging for key players.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1326

Regenerative Medicine Market: Segmentation

Regenerative medicine market is classified on the basis of technology, application and geography.

Based on technology, the regenerative medicine market is segmented into the following:

  • Tissue Engineering
  • Biomaterials
  • Scaffolds
  • Cells
  • Biologically Active Materials
  • Stem Cell Therapy Or Cellular Therapeutics
  • Autologous
  • Allogeneic

Based on application, the regenerative medicine market is segmented into the following:

  • Cardiology
  • Orthopaedics
  • Wound Healing
  • Diabetes
  • Neurodegenerative Disease
  • Musculoskeletal Regeneration
  • Otorhinolaryngology

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1326

Based on geographically, the regenerative medicine market is segmented into following:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

Regenerative Medicine Market: Overview

Regenerative medicine market is expected to expand at healthy CAGR during the forecast period due to high demand for regenerative medicine in chronic disease cases. The rapid advancement in technology, usages in multiple applications and increasing cases of chronic disease are some of the key factors to drive the growth of regenerative medicines market globally. Developing countries will be growing with a higher CAGR compared to other parts of the world because of the technological improvement, flexible regulations and increasing awareness.

Regenerative Medicine Market: Region-wise Outlook

Depending on geographic region, regenerative medicine market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Japan, Asia Pacific and Middle East & Africa. North America will contribute the maximum in regenerative medicine market share. Eastern and Western Europe will show a good growth as the need for transplants through regenerative medicine will be increasing for wide range of applications such as cardiology, orthopedics, diabetes neurodegenerative disease. Japan having a well establish economy, CAGR of regenerative medicine market is expected to be higher compare to other developed countries. Asia Pacific is growing with a significant CAGR for regenerative medicine market due to increase in healthcare expenditure and investment in research. Amongst the Asian countries, China and South Korea will be the more promising because of having a good base of research.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/regenerative-medicine-market

Regenerative Medicine Market: Key Players

Some of the key participating global players in regenerative medicine market are OncoMed Pharmaceuticals, BrainCells, Five Prime Therapeutics, Pieris AG, Tyrx Pharma, Aldagen, Histogenics, Fate Therapeutics,  iZumi Bio, Neurologix, Inc., Cellerant Therapeutics, Inc., Stem Cell Sciences plc., Cellerant Therapeutics, Inc., Embryome Sciences, Inc., Chromos Molecular Systems, Aastrom Biosciences, BioRestorative, Dendreon, Histogenics, Nanotope, Cell Medica, RTI Surgical, Neuralstem, Fate Therapeutics and others.

Global Tumour Ablation Devices Market Set for Rapid Growth And Trend, by 2026

FMI_FacebookTumors are the groups of abnormal cells that accumulate together and form lumps and grow consistently. Tumors are categorized into noncancerous and cancerous tumors. Precancerous conditions have the potential of developing into cancer. Tumor ablation is a tool utilized to treat cancerous malignancy. Tumor ablation is the process of removing the cancerous cells from the body. Tumor ablation became more useful during 1970s and 1980s due to advances in laparoscopic surgical approach. The most common means for definitive treatment of primary and metastatic focal malignancy, is the evolution of imaging devices during the past two decades and image-guided tumor ablation.

Tumour Ablation Devices Market: Drivers & Restraints

Increasing prevalence and incidences of cancers, technological advances and increasing geriatric population, increasing numbers of hospitals and healthcare awareness are facilitating the growth of global tumor ablation devices market. Additionally, economic pricing, short recovery time, low risk of infection, and minimal hospital stays are increasing the importance of tumor ablation devices. Side effects associated with ablation treatment and limited performance of the devices are the factors restraining the growth of global tumor ablation device market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1325

Tumour Ablation Devices Market: Segmentation

The global tumor ablation devices market has been classified on the basis of product type, application and end user:

On the basis of product type, the tumor ablation devices market is segmented into the following

  • Radiofrequency ablation
  • Laser ablation
  • High intensity focused ultrasound ablation
  • Microwave ablation
  • Cryo ablation

Based on application type, the tumor ablation devices market is segmented into the following:

  • Liver Cancer
  • Kidney Cancer
  • Colorectal Cancer
  • Bone Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers

Based on end use type, the tumor ablation devices market is segmented into the following:

  • Hospitals
  • 500 and more beds hospitals
  • 200 to 499 beds hospitals
  • Less than 200 beds hospitals
  • Ambulatory Surgical Centers

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1325

Tumour Ablation Devices Market: Overview

The lung cancer application segment is expected to grow at the highest CAGR in the next five years due to large patient population of lung cancer present across developing and developed regions. This has increased the investment of manufacturers to develop and commercialize innovative lung cancer ablation products. The radiofrequency ablation is widely used technique due to specificity of treating target tissue without causing damage to the surrounding cells. Microwave ablation product segment is expected to grow significantly due to increase in adoption rate of microwave ablation devices by healthcare professionals.

Tumor Ablation Devices Market: Region-wise Outlook

Region wise, the global tumor ablation market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. The global market is expected to be dominated by North America due to factors such as early introduction and adoption of rate of tumor ablation products in the region, trend of replacing older technologies and introducing the new technologies, and increase in private and public funding to develop and commercialize the novel tumor ablation products. The Asia-Pacific market is expected to grow at a higher CAGR in the forecast period due to factors such as large population with the high prevalence of various cancers in the region, government initiatives for developing and modernizing the healthcare infrastructure.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/tumour-ablation-devices-market

Tumour Ablation Devices Market: Key Players

Key players of tumor ablation devices market are Boston Scientific Corporation, St. Jude Medical, Inc., Biotronic NeuroNetwork, LLC, Baylis Medical, biolitec AG, Spectranetics, Esaote SpA, ALPINION MEDICAL SYSTEMS Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., Koninklijke Philips N.V, Hironic Co., Ltd., Monteris Medical, Inc, EDAP TMS, EYE TECH CARE, NeuWave Medical, Inc, Vison medical, AtriCure, Inc, Galil Medical Inc, ENDOCARE INC, IceCure Medical, Sanarus HealthTronics, Inc, MEDTRONIC, MedWaves, AngioDynamics, Microsulis Medical, Perseon, SympleSurgical Inc. to name a few.

FMI Releases New Report on the Allergic Conjunctivitis Treatment Market 2016-2026

FMI_FacebookSwelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due to allergens in patients such as household dust, mold spores, pollen from trees and grass, chemical scents (e.g., household detergents or perfume) and animal dander. Allergic conjunctivitis treatment includes medication for redness and inflammation caused to the conjunctiva. International Ocular Inflammation Society (IOIS) describes allergic conjunctivitis as a type of ocular allergy that is further classified into two types, namely, seasonal allergic conjunctivitis and perennial allergic conjunctivitis. In the U.S., allergic conjunctivitis affects 15-20% of the general population while in other parts of the world, the estimates vary from 5-22% depending upon the topographical and demographic variations annually.

Allergic Conjunctivitis Treatment Market: Drivers and Restraints

Enhanced awareness about allergic conjunctivitis among the patients, medical community and people associated with the patients is one of the major driver for the growth of global allergic conjunctivitis market. Development in lifestyle and overall growth in number of patients suffering from allergic conjunctivitis are key factors boosting the growth of the global allergic conjunctivitis market. Hence, treatments that can reduce allergic conjunctivitis are in demand. However, high cost associated with clinical trials acts as a major barrier for global allergic conjunctivitis market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1318

Allergic Conjunctivitis Treatment Market: Segmentation

Allergic conjunctivitis market is classified on the basis of allergy type, drug type and geography.

Based on the type of allergy, the global allergic conjunctivitis market is segmented into the following:

  • Acute Allergic Conjunctivitis
  • Chronic Allergic Conjunctivitis

Based on the drug type, the global allergic conjunctivitis market is segmented into the following:

  • Antihistamines
  • Vasoconstrictors
  • Mast Cell Stabilizers
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
  • Corticosteroids

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1318

Global Allergic Conjunctivitis Market: Overview

Rapid technological advancement, increase in the number of patients, increasing aging population, increasing demand for efficient drug types, increase in the incidence and prevalence of allergic conjunctivitis cases is expected to fuel growth of the global allergic conjunctivitis market during forecast period.

Global Allergic Conjunctivitis Market: Region-wise Outlook

Depending on geographic regions, global allergic conjunctivitis market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America is the largest market owing to the high prevalence of allergic conjunctivitis in the region. According to estimates, approximately 60 Mn to 90 Mn Americans suffer from ocular allergy. The APAC market is poised to grow rapidly in the near future owing to large population base which boosts demand for better healthcare facilities. Rapid urbanization and increasing particulate pollution has increased incidences of allergic conjunctivitis in several Asian countries such as India even though, the market has certain restraints such as awareness among general public regarding eye disorders and lack of health insurance.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/allergic-conjunctivitis-treatment-market

Global Allergic Conjunctivitis Market: Key Players

Some of the key players in the global allergic conjunctivitis treatment market are Boehringer Ingelheim GmbH, Allergan Inc., Sanofi-Aventis, Novartis AG, Bausch & Lomb Inc., CIBA Vision Ophthalmics, Pfizer Inc., Merck & Co., Inc., and Santen Pharmaceuticals Co. Ltd.

Good Growth Opportunities in Global Cosmetic Surgery Products Market Till 2026, Finds New Research Report

FMI_FacebookCosmetic surgery is a process that enhances or alters a portion of an individual’s body, or, face through incision. Cosmetic surgeries include reconstruction or reshaping of body parts, altering facial structure (maxillofacial), altering structure of jaw (craniofacial), etc. People from urban areas constitute the largest patient base for cosmetic surgeries due to increased aesthetic appeal.

In developed countries such as United States, cosmetic surgeries procedures such as liposuction, reshaping, implants, lifts, tucks, injections, resurfacing, and laser treatments are gaining increased popularity. Major products used in these procedures include injectable, silicone or polymer implants, energy based equipment such as lasers, ultrasound and radiofrequency devices. Some of the other devices used in cosmetic surgery include anti-cellulite treatment devices that help in toning the body parts and microdermabrasion devices are used to treat fine lines, wrinkles, age spots, light scarring, and discoloration of the skin, blemishes, acne and sun damage, among other conditions.

Cosmetic Surgery Products Market: Drivers and Restraints

Major drivers for the market include rising disposable income levels in developed countries coupled with increasing social awareness, glossy advertisements creating customer-pull effects within entertainment industry, rise of medical tourism in emerging countries such as Brazil and UAE, early adoption of invasive and minimally invasive surgical procedures for remaining youthful, and increase in number of traumatic injuries requiring reconstructive changes.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1319

Major restraints for the market include high costs of treatments including physician’s fees, slower adoption in satellite cities in emerging countries and very little or no availability of reimbursement options in developed countries.

Cosmetic Surgery Products Market: Segmentation

Global cosmetic surgery Products market is segmented into following types:

By Product Type:

  • Implants
  • Breast Implants
  • Chin & Cheek Implants
  • Injectable
  • Botulinum Toxin
  • Soft Tissue Fillers
  • Dermal Fillers
  • Absorbable fillers
  • Non-absorbable fillers
  • Lasers
  • Ablative Laser
  • Non-Ablative Laser
  • Micro dermabrators
  • Liposuction Equipment
  • Services

By application in body parts

  • Face
  • Upper Body
  • Breasts
  • Hands
  • Stomach
  • Lower Body

By End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Universities and research centers
  • Homecare Settings

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1319

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Cosmetic Surgery Products Market: Overview

The global market for cosmetic surgery is expected to register a healthy CAGR during the forecast period. Early onset of ageing, expanding geriatric age groups opting for cosmetic surgeries, increasing accidents demanding reconstructive changes and enhanced purchase power in developing countries are some of the factors expected to create increased adoption for cosmetic surgery is expected to have a healthy growth rate in the forecast period (2016-2026).

Cosmetic Surgery Products Market: Region-wise Outlook

The market for cosmetic surgical devices is relatively smaller when compared to cosmetic surgery services.  Early onset of ageing, rising number of trauma cases and accidents, relentless quest to remain youthful and defy ageing, rising purchasing power and greater awareness towards advanced procedures are a few factors creating the icing of the cosmetic surgery industry. Deeper analysis into cosmetic surgery trends and product development is expected to create solutions for untapped needs of the broader market. In terms of countries, undoubtedly U.S. is the market leader in terms of number of surgical procedures conducted per year followed by Europe. However, rising awareness and easier availability of services at attractive rates is expected to huge potential in the emerging countries of Asia Pacific, Latin America and Eastern Europe.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/cosmetic-surgery-products-market

Cosmetic Surgery Products Market: Key Players

Some of the key players in global cosmetic surgery market are Allergan, Mentor Corporation, Candela Corp, Cutera Inc, Lumenis Ltd., Palomar Medical, Iridex Corp, Solta Medical, DermaMed Pharmaceutical Inc, Medtronic plc, Johnson & Johnson Services, Inc. Syneron Medical Ltd., Cynosure Inc. and several others.

Good Growth Opportunities in Global Analgesics Market Till 2026, Finds New Research Report

FMI_FacebookAnalgesics are the medicines that alter perception, sensation, and sometimes also affects consciousness of individuals by blocking nerve impulses selectively to provide relief from pain. Analgesic drugs are generally available in three categories namely non-steroidal anti-inflammatory drugs (NSAID), opioids, and local anesthetics. The NSAID reduces pain by selectively reducing the local inflammatory reactions, opioids have their action on the brain and are utilized both in short-term and long-term relief from severe pain, while local anesthetics block the generation and the conduction of nerve impulses. Thus, analgesics form one of the largest markets in the overall pharmaceutical drugs market.

Analgesics Market: Drivers and Restraints

High prevalence of pain worldwide, driven by an increase in the many disorders related with pain, is highly endorsing the growth of analgesics market. In addition, aging population, increasing acceptance of analgesics drugs, addition of new drugs, rising consumer awareness levels and increasing effective treatment opportunities are responsible for driving analgesics market. Growing geriatric population will be the most important growth driver for this market as such population suffer from pain due to various diseases that occurs in the old age. Due to the increasing therapeutic benefits offered by such drugs along with the faster and effective pain relief, analgesics find increased acceptance by geriatric population. The new innovative drug treatments in the category and increasing awareness about such treatments would drive the growth of this market further in future. However, chronic side effects, susceptible to abuse, high prices of drugs, limited commercialization of new products, and stringent government policies would hinder the growth of analgesics market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Analgesics Market: Segmentation

The global analgesics market has been classified on the basis of therapeutics class, pain type, and application.

By therapeutics class, the global analgesics market is segmented into the following:

  • NSAID
  • Opioids
  • Local anesthetics
  • Others
  • Antidepressants
  • Antimigrain agents
  • Neuroleptics
  • Anxiolytics
  • Anticonvulsants
  • Triptans, ergot alkaloids

Based on application, the global analgesics market is segmented into the following:

  • External Analgesics
  • Internal Analgesics

Based on pain type, the global analgesics market is segmented into the following:

  • Neuropathic pain
  • Inflammatory pain
  • Surgical pain
  • Cancer pain
  • Wound care pain
  • Physiologic pain
  • Phantom
  • Pain arising from other diseases
  • Others

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1306

Analgesics Market: Overview

By therapeutic class, NSAID holds prominent share owing to high unmet medical requirements in pain management segment. By application, internal analgesics is leading the analgesic market. Acetaminophen, a drug under internal analgesics segment is representing the largest product segment. External analgesics market is also growing evidently due to introduction of new competitors in the market, and increased advertising.

Analgesics Market: Region-wise Outlook

Geographically, North America is the largest analgesics market followed by the Europe. The aging population in the U.S. is the major factor for the region to contribute maximum towards this market. The new opioids and non-opioids will also help meet the unmet needs of the large geriatric population of the region. Europe is also bound to grow due to their high geriatric population and commercialization of new drugs. Asia-Pacific market will experience the highest rate of growth due to the increasing consumer awareness and increasing healthcare expenditure in the region.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/analgesics-market

Analgesics Market: Key Players

Key companies operational in analgesics market are Actavis, Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Novartis AG, Johnson & Johnson, Pfizer, Inc., Sanofi, GlaxoSmithKline plc, Reckitt Benckiser plc and Teva Pharmaceutical Industries Ltd.